.
Objectives: Radiation-induced hypothyroidism (RIHT) is a common late toxicity after head and neck radiotherapy. We aimed to develop and externally validate a multimodal Cox model for patient-specific cumulative RIHT risk assessment. Materials & methods: This retrospective multicentre study included 1407 patients across four cohorts. The model was developed in the training cohort and externally validated in three independent cohorts. Candidate predictors included CT radiomics, dosiomics, dose-volume histogram parameters, and clinical variables. A multimodal Cox model was developed and used to estimate cumulative risks across time horizons. Temporal risk groups were derived from predicted 3-and 7-year risks. Results: A total of 1407 patients (mean age, 55.4 +/- 13.8 years; 1027 men) were evaluated and RIHT occurred in 694 (49.3%). The final model integrated three CT radiomics features, four dosiomics features, mean thyroid dose, age and N stage. It achieved C-index/overall AUC values of 0.714/0.765 in the development cohort and 0.725/ 0.800, 0.680/0.754, and 0.627/0.690 in the three external validation cohorts. Four temporal risk groups had RIHT event rates of 21.7%, 46.1%, 58.3%, and 71.8%, with significant differences in RIHT-free survival (log-rank p < 0.001). The model was packaged as an open-source software tool for individualised risk assessment. Conclusion: The externally validated multimodal Cox model provided time-resolved, patient-specific RIHT risk estimates and temporal risk stratification using routinely available radiotherapy-planning data.
To compare perioperative, oncological, and survival outcomes of total gastrectomy (TG) versus subtotal gastrectomy (SG) in patients with locally advanced distal diffuse gastric adenocarcinoma treated with perioperative 5-fluorouracil, leucovorin, oxaliplatin and docetaxel (FLOT) chemotherapy. Diffuse distal gastric cancer is characterized by infiltrative growth patterns and early nodal metastasis. Whilst radical resection remains the cornerstone of curative treatment, the optimal extent of surgery with TG or SG, remains debated. This international multicenter cohort study analyzed data from patients with histologically confirmed diffuse gastric adenocarcinoma, located > 5 cm from the gastroesophageal junction. Endpoints included surgical margin status, nodal yield, perioperative morbidity, recurrence patterns, time-to-recurrence (TTR), and overall survival (OS). Outcomes were compared using multivariate analyses. In total, 188 (39.0
Copeptin is an emerging biomarker for polyuria-polydipsia syndrome. Postoperative copeptin levels may predict acquired arginine vasopressin deficiency (AVP-D). This prospective study evaluated the diagnostic performance of serum copeptin for predicting postoperative AVP-D after transsphenoidal surgery (TSS). Copeptin was measured preoperatively, immediately after surgery (periextubation, T0), upon first ward arrival (T1), daily until discharge, and at week 2. Delta copeptin was calculated as the percentage change from T0 to T1. Of 53 patients, 23 (43.4
The purpose of this study is to assess incidence, temporal trend, risk factors, clinical characteristics, management and outcomes of systemic hypertension (SH) in very preterm infants. We conducted a retrospective population-based study including preterm infants born at < 31 weeks’ gestation in Nova Scotia and Prince Edward Island, Canada, between 2002 and 2016. Patients diagnosed with SH requiring treatment before discharge from the NICU, or on 3 consecutive occasions during outpatient follow-up, were compared with matched controls (for gestational age, sex and birth weight). Perinatal data, details of SH, neonatal course and neurodevelopmental outcomes at 18 months corrected gestational age were reviewed. Of the 935 infants who met inclusion criteria, 102 (10.9